Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKinsey
Harvard Business School
Johnson and Johnson
Colorcon

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Litigation Details for University of Pittsburgh of the Commonwealth System of Higher Education v. Varian Medical Systems, Inc. (N.D. Cal. 2008)

See Plans and Pricing

« Back to Dashboard

University of Pittsburgh of the Commonwealth System of Higher Education v. Varian Medical Systems, Inc. (N.D. Cal. 2008)

Docket   Start Trial Date Filed 2008-06-16
Court District Court, N.D. California Date Terminated 2008-09-16
Cause 28:1338 Patent Infringement Assigned To Maxine M. Chesney
Jury Demand Plaintiff Referred To
Parties UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; VARIAN MEDICAL SYSTEMS, INC.
Patents 10,099,009; 9,205,056
Attorneys Daniel Johnson , Jr.; Matthew Herman Poppe; Rita Emily Tautkus; William L. Anthony , Jr.; Zheng Liu
Firms Morgan Lewis & Bockius; Orrick Herrington & Sutcliffe LLP
Link to Docket External link to docket
Biologic Drugs cited in University of Pittsburgh of the Commonwealth System of Higher Education v. Varian Medical Systems, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for University of Pittsburgh of the Commonwealth System of Higher Education v. Varian Medical Systems, Inc. (N.D. Cal. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-06-16 1 Complaint 413.25, 413.26; 356!375; 37%9, 205 [56] . References Cited U.S. PATENT DOCUMENTS 4,466,075 8/1984 Gnoch…11356 l coMPLAINT FoR PATENT INFRINGEMENT oF 1"’ 7 ' THE 554 AND 431 PATENTS v 10 11 12 13 …. 2 COMPLAINT FOR PATENT INFRINGEMENT OF l-PA/37l 1356-l THE 554 AND 431 PATENTS 10 11 12 13 14 …UPitt is the owner of United States Patent No. 5,727,554 (the 554 Patent), entitled “Apparatus Responsive…Treatment/Diagnosis.” The 554 Patent was duly and legally issued by the Patent and Trademark Office on March External link to document
2008-06-27 17 Motion to Transfer Case Pittsburgh. See, e.g., id., Ex. A at 25 96:10-99:9, 138:17-143:16; id., Ex. B at 35:14-38:25, 61:15-64:14… two patents: U.S. Patent 5 Nos. 5,727,554 and 5,784,431 (the “‘554 patent” and “‘431 patent,” respectively…disputed patents, the prosecution of the patents, the record considered by the 18 Patent Office in…alleged infringement of the ‘554 11 patent and the ‘431 patent. See RJN, Ex. A.2 The accused products… based on the patent venue statute, which provides that “[a]ny civil action for patent infringement 19 External link to document
2008-06-16 6 Patent/Trademark Copy 413.25, 413.26; 356!375; 37%9, 205 [56] . References Cited U.S. PATENT DOCUMENTS 4,466,075 8/1984 Gnoch…11356 l coMPLAINT FoR PATENT INFRINGEMENT oF 1"’ 7 ' THE 554 AND 431 PATENTS v 10 11 12 13 …. 2 COMPLAINT FOR PATENT INFRINGEMENT OF l-PA/37l 1356-l THE 554 AND 431 PATENTS 10 11 12 13 14 …UPitt is the owner of United States Patent No. 5,727,554 (the 554 Patent), entitled “Apparatus Responsive…Treatment/Diagnosis.” The 554 Patent was duly and legally issued by the Patent and Trademark Office on March External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Moodys
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.